A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma (clinicaltrials.gov) - Oct 14, 2026 - P3 | N=510 | Active, not recruiting | Sponsor: Shandong Boan Biotechnology Co., Ltd | Recruiting ➔ Active, not recruiting | Trial primary completion date: Jun 2025 ➔ May 2026
Enrollment closed • Trial primary completion date • Esophageal Cancer • Esophageal Squamous Cell Carcinoma • Oncology • Squamous Cell Carcinoma • PD-L1
|